Ian Michael Bouligny (Ian M Bouligny)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Venues

Medical oncology (Northwood, London, England)

EJHaem

Research square

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Ian Michael Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Thuy Ho, Kyle Zacholski, Chad Venn, Nolan A Wages, Steven Grant, Keri R Maher
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia. Medical oncology (Northwood, London, England) 41 (3) (2024)
Ian Michael Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Thuy Ho, Kyle Zacholski, Chad Venn, Nolan A Wages, Steven Grant, Keri R Maher
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia. Medical oncology (Northwood, London, England) 41 (3) (2024)
Ian Michael Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Thuy Ho, Kyle Zacholski, Chad Venn, Nolan A Wages, Steven Grant, Keri R Maher
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia. Medical oncology (Northwood, London, England) 41 (3) (2024)
Ian Michael Bouligny, Graeme Murray, Thuy Ho, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Nolan A Wages, Steven Grant, Keri R Maher
Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia. Research square (2023)
Ian Michael Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Nolan A Wages, Steven Grant, Keri R Maher
Venetoclax with decitabine or azacitidine in the first-line treatment of acute myeloid leukemia. EJHaem 4 (2) (2023)
Ian Michael Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Nolan A Wages, Steven Grant, Keri R Maher
Venetoclax with decitabine or azacitidine in the first-line treatment of acute myeloid leukemia. EJHaem 4 (2) (2023)
Ian Michael Bouligny, Keri R Maher, Steven Grant
Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022. Cancers 15 (13) (2023)
Ian Michael Bouligny, Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran, Juhi Gor, Yiwei Hang, Yanal Alnimer, Kyle Zacholski, Chad Venn, Nolan A Wages, Steven Grant, Keri R Maher
Venetoclax with decitabine or azacitidine in the first-line treatment of acute myeloid leukemia. EJHaem 4 (2) (2023)
Keri R Maher, Ian Michael Bouligny, Andrew M Yeager
Prevention and management of infections after exposure to ionising radiation. Journal of radiological protection : official journal of the Society for Radiological Protection 41 (4) (2021)

Ian Michael Bouligny.css-eqlu8i{font-size:small;padding-left:4px;} (Ian M Bouligny)

Publication Activity (10 Years)

Top Topics

Top Venues

Ian Michael Bouligny (Ian M Bouligny)